Creative Planning
PRME icon

Creative Planning’s Prime Medicine PRME Stock Holding History

Creative Planning’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$98.3K Buy
28,246
+10,354
+58% +$39.4K ﹤0.01% 3907
2025
Q4 		$62.1K Sell
17,892
-5,190
-22% -$23.1K ﹤0.01% 3779
2025
Q3 		$128K Buy
23,082
+12,937
+128% +$52.6K ﹤0.01% 3630
2025
Q2 		$25.1K Buy
+10,145
New +$15.6K ﹤0.01% 3582
2025
Q1 		– Sell
-27,623
Closed -$80.7K – 3670
2024
Q4 		$80.7K Buy
+27,623
New +$97K ﹤0.01% 3186

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Creative Planning's PRME Position: Q1 2026 in Review

Creative Planning increased its Prime Medicine (PRME) stake by 58% in Q1 2026, buying an estimated $39.4K and bringing the position to 28,246 shares worth $98.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3907.

Creative Planning first reported a position in PRME in Q4 2024 and has held it in 5 quarters since. The position peaked at $128K in Q3 2025. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • Creative Planning held 28,246 shares of Prime Medicine worth $98.3K as of Q1 2026.
  • Creative Planning bought 10,354 Prime Medicine shares in Q1 2026, an estimated $39.4K.
  • Prime Medicine made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #3907 holding.
  • Creative Planning first reported a position in Prime Medicine in Q4 2024 and has held it in 5 quarters since.
  • Creative Planning's Prime Medicine position peaked at $128K in Q3 2025.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.